L'anemie chronique dans les maladies inflammatoires de l'intestin: revue de litterature

[en] Chronic anemia has been considered as an overlooked complication of inflammatory bowel disease (IBD). However it deserves full attention since even mild to moderate anemia has significant impact on quality of life. During the past decade relevant progress has been made in the understanding and treatment of this pathology. In our review, we focus on frequency, mechanisms, diagnosis and treatment of anemia in IBD.

Disciplines :

Gastroenterology & hepatology

Author, co-author :

Vijverman, A.

Belaiche, Jacques ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie

Louis, Edouard ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie

Language :

French

Title :

L'anemie chronique dans les maladies inflammatoires de l'intestin: revue de litterature

Alternative titles :

[en] Chronic Anemia in Inflammatory Bowel Diseases: Review

Publication date :

November 2005

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

888-92

Peer reviewed :

Peer reviewed

Available on ORBi :

since 26 November 2009

Statistics

Number of views

169 (0 by ULiège)

Number of downloads

58 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Gasche C, Reinisch W, Lochs H, et al.- Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci, 1994, 39, 1930-34
Gasche C.- Anemia in IBD: The Overlooked Villain. Inflamm Bowel Dis, 2000, 6, 142-150
Krantz SB.- Erythropoietin and the anemia of chronic disease. Nephrol Dial Transplant, 1995, 10, 10-7
Evans RW, Rader B, Manninen DL.- The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. JAMA, 1990, 263, 825-30
Grimm G, Stockenhuber F, Scheeweiss B, et al.- Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int, 1990, 38, 480-6
Leitgeb C, Pecherstorfer M, Fritz E, et al.- Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer, 1994, 73, 2535-42
Best WR, Becktel JM, Singleton JW.- Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology, 1979, 77, 843-6
Gasche C, Dejaco C, Waldhoer T, et al.- Intravenous iron and erythropoietin for anemia associated with Crohn's disease. Ann Intern Med, 1997, 126, 782-787
Mac dougall IC.- Quality of life and anemia: the nephrology experience. Semin Oncol, 1998, 25, 39-42
Macdougall IC.- Srategies for iron supplementation: oral versus intraveinous. Kidney int, 1999, 69, s61-s66
Beal RW, Skyring AP, McRae J, et al.- The anemia of ulcerative colitis. Gastroenterology, 1963, 45, 589-603
Both H, Trop-Pedersen K, Kreiner S, et al.- Clinical appearance at diagnosis of ulcerative colitis and Crohn's disease in a regional patient group. Scan J Gastroenterol, 1983, 18, 987
Ormerod TP.- Observation on the incidence and cause of anemia in ulcerative colitis. Gut, 1967, 8, 107-114
Schreiber S, Howaldt S, Schnoor M, Net al.- Erythropoietin for inflammatory bowel disease anemia. Gastroenterology, 1997, 112,660-665
Mahida YR, Wu K, Jewell DP.- Enhance production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease.Gut, 1989, 30, 835-8
MacDonald TT, Hutchings P, Choy MY, et al.- Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed humane intestine. Clin Exp Immunol, 1990, 81, 301-305
Tilbrook PA, Klinken SP.- The erythropoietin receptor. Int J Biochem Cell Biol, 1999, 73, 2535-42
Child JA, Broezvic B, Dyer NH, et al.- The diagnosis of iron deficiency in patients with Crohn's disease. Gut, 1973, 14, 642-8
Bartels U, Pedersen NS, Jarnum S.- Iron absorption and serum ferritin in chronic inflammatory bowel disease. Scan J Gastroenterol, 1978, 13, 649-56
Thomson ABR, Brust R, Ali MAN, et al.- Iron deficiency in inflammatory bowel disease. Am J Dig Dis, 1978, 23, 705-709
PunnonenK, Irjala K, Rajamaki A.- Serum transferring receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood, 1997, 89, 1052-7
Ligumsky M, Simon PL, Karmeli F, et al.- Role of interleukin Iβ in inflammatory bowel disease- enhanced production during active disease. Gut, 1990, 31, 686-9
Reinecker HC, Steffen M, Witthoeft T, et al.- Enhanced secretion of tumor necrosis factor a, IL6, and ILIβ by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol, 1990, 81, 301-5
Horina HJ, Petritsch W, Schmid CR, et al.- Treatment of anemia in inflammatory bowel disease with recombinant human erythropoietin: results in three patients. Gastroenterology, 1993, 104, 1828-31
Means RTJ, Krantz SB.- Progress in understanding the pathogenesis of the anemia of chronic disease. Blood, 1992,80, 1639-47
Means RT Jr.- Advances in the anemia of chronic disease. Int J Hematol, 1999, 70, 7-12
Macdougal IC, Cavill I, Hulme B, et al.- Detection of functional iron deficiency during erythropoietin treatmen: a new approach. BMJ, 1992, 304, 225-6
Means RTJ, Dessypris EN, Krantz SB.- Inhibition of human erythroid colony-forming units by interleukin is mediated by interferon. J Cell Physiol, 1992,150, 59-64
Fanquin WC, Schneider TJ, Goldberg MA.- Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood, 1992, 79, 1987-1994
Eschbach JW, Adamson JW- Guidelines for recombinant human erythropoietin therapy. Am J Kidney Dis, 1989,14,2-8
Baer AN, Dessypris EN, Goldwasser E, et al.- Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol, 1987, 66, 559-564
Hochberg MC, Arnold CM, Hogans BB, et al.- Serum immunoreactive erythropoietin in rheumatoid arthritis: Impaired response to anemia. Arthritis Rheum, 1988,31, 1318-1321
Miller CB, Jones RJ, Piantadosi S, Aet al.- Decreased erythropoietin response in patients witn the anemia of cancer. N Engl J Med, 1990,322, 1689-1692
Gasche C, Dejaco C, Reinisch W, et al.- Sequential treatment of anemia in ulcerative colitis with intraveinous iron and erythropoietin. Digestion, 1999, 60, 262-267
Boyd HK, Lappin TRJ.- Erythropoietin deficiency in the anemia of chronic disorder. Eur J Haematol, 1991, 46, 198-201
Gasche C, Waldhoer T, Feichtenschalgr T, Met al.- Prediction of response to iron sucrose in inflammatory bowel disease- associated anemia. Am J Gastroenterol, 2001,96,2382-2387
Yates P, Macht M, Williams NA, et al.- Red blood cell autoantibody production by colonic mononuclear cells from a patient with ulcerative colitis and autoimmune haemolytic anemia. Br J Haematol, 1992, 82, 753-756
Kaplinsky N, Frankl O.- Salicylazosulphapyridine-induced Heinz body anemia. Acta Haematol, 1978, 59, 310-314
Babbs C.- Oxygen radicals in ulcerative colitis. Free Radic Biol Med, 1992,13, 169-181
de Silva A, Mylonaki M, Rampton D.- Oral iron therapy in inflammatory bowel disease: usage, tolerance and efficacity. Inflammatory Bowel Disease, 2003, 9, 316-320
Gordeuk VR, Brittenham GM, Bravo J, et al.- Prevention of iron deficiency with carbonyl iron in female blood donors. Transfusions, 1990, 30, 239-245